Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Oligomerization of ZASP, a myofibrillar myopathy gene product, in vitro and in vivo
Neuromuscular and Clinical Neurophysiology (EMG)
(-)
058
Authors/Disclosures
Lisa Brubaker
PRESENTER 		No disclosure on file
Rachel Ohman No disclosure on file
No disclosure on file
No disclosure on file
Ami K. Mankodi, MD, FÂ鶹´«Ã½Ó³»­ (FDA) No disclosure on file
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­ (Buffalo Neuroimaging Analysis Center) The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.